Telehealth in Improving Quality of Life in Patients During Post Radiation Therapy Visits

NCT02751580 | Completed Results DMC

• 2 other identifiers: 15D.580JT 8256
• Study Type: interventional
• Target: 37
• Locations: 1 country
• Sites: 1

Brief Summary

This pilot clinical trial studies how well telehealth works in patients during post radiation therapy visits. A telehealth virtual office visit can be performed from the patient's home or workplace, decreasing time spent traveling to visit site, time spent in waiting room, and cost to patient. Studying telehealth may improve quality of life in patients during post radiation therapy visit.

Conditions

Malignant Neoplasm

Outcome Measures

Primary Outcomes (1)

• Feasibility of Conducting a Future Randomized Clinical Trial Comparing Telehealth and in Person Visits (i.e., Rate of Accrual)

  The number of patients accrued each month will be analyzed via Poisson regression. The mean (monthly rate) will be estimated and tested against the null value of 4 patients per month using a 1-sided test with alpha 0.05. The proportion of enrolled subjects who are lost to follow-up will also be summarized.

  24 months from first patient enrolled

Secondary Outcomes (7)

• Patient Satisfaction With Telehealth Visits as Measured by the Patients Satisfaction With Cancer Care Score

  4 months from enrollment

• Number of Patients Satisfied With Physician Communication During Telehealth Visit

  4 months from enrollment

• Patient Distrust in the Healthcare System as Measured by the Health Care System Distrust Scale in Relation to Privacy of Medical Record (MR)

  4 months from enrollment

• Physicians Ability to Evaluate a Patient During a Telehealth Visit as Measured by the Physician Questionnaire

  4 months from enrollment

• Physician Satisfaction With Post-treatment Telehealth Visit as Measured by the Modified Physician Satisfaction Scale

  4 months from enrollment

Study Arms (1)

Health services research (telehealth)

EXPERIMENTAL

Patients undergo their first post-treatment visit as a virtual telehealth visit using the JeffConnect application downloaded onto their electronic device.

Other: Telemedicine; Other: Questionnaire Administration

Interventions

Telemedicine OTHER

Attend a virtual visit via the JeffConnect telehealth app

Also known as: Telehealth

Health services research (telehealth)

Questionnaire Administration OTHER

Ancillary studies

Health services research (telehealth)

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Patients currently undergoing or planned to start radiation treatment with curative, adjuvant or palliative intent
• Karnofsky performance status (KPS) score \>= 60
• Patients must be capable to read and speak English and provide study specific informed consent prior to study entry
• Patients must have access to a computer or smartphone and internet connection at home on which they would be willing to do a telehealth study
• Pennsylvania or New Jersey residents \*Telehealth visits for New Jersey residents will only be performed by physicians with a current medical license issued by the state of New Jersey.

You may not qualify if:

• KPS \< 60%
• No access to a computer, smartphone or internet
• Unable to read and/or speak English
• Decisionally impaired patients
• Patients not residing in Pennsylvania or New Jersey

Sponsors & Collaborators

• Sidney Kimmel Cancer Center at Thomas Jefferson University: lead

Study Sites (1)

Thomas Jefferson University

Philadelphia, Pennsylvania, 19107, United States

Location

Related Links

• Sidney Kimmel Cancer Center at Thomas Jefferson University, an NCI-Designated Cancer Center
• Jefferson University Hospitals

MeSH Terms

Conditions

Neoplasms

Interventions

Telemedicine

Intervention Hierarchy (Ancestors)

Delivery of Health Care; Patient Care Management; Health Services Administration

Results Point of Contact

• Title: Nicole Simone, MD
• Organization: Sidney Kimmel Cancer Center at Thomas Jefferson University

nicole.simone@jefferson.edu

215-955-6702

Study Officials

• Nicole Simone, MD

  Thomas Jefferson University

  PRINCIPAL INVESTIGATOR

Publication Agreements

• PI is Sponsor Employee: Yes

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: HEALTH SERVICES RESEARCH
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: April 11, 2016
• First Posted: April 26, 2016
• Study Start: March 23, 2016
• Primary Completion: August 8, 2018
• Study Completion: August 8, 2018
• Last Updated: May 16, 2025
• Results First Posted: December 31, 2020

Record last verified: 2025-05

Locations

US (1)